Companies: 10,795·Total market cap: $144.5T
iSpecimen Inc.

iSpecimen Inc.

ISPCNASDAQHealthcare● Active
$2.95
$-0.07(-2.32%)
Market Cap$409643
P/E Ratio—
52W High$127.2
52W Low$2.9
Shares OutstandingFinancialsRevenue

iSpecimen Inc. (ISPC) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

ISPC · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
115,062▲ +547.47% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 17,771 in FY 2024
Diluted Shares Outstanding
115,062
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+547.47%
year-over-year
Float (Free Float)
137,491
publicly tradable shares
99.0% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+118.4%
2022 → 2025
5-Year CAGRincreasing
+150.3%
2020 → 2025
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 115,062
115,062
+547.47%
FY 2024
Diluted Shares: 17,771
17,771
+57.24%
FY 2023
Diluted Shares: 11,302
11,302
+2.36%
FY 2022
Diluted Shares: 11,055
11,041
+8.08%
FY 2021
Diluted Shares: 10,216
10,216
+773.16%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs ISPC
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
iSpecimen Inc.ISPC
iSpecimen Inc.YOU
115,062—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

iSpecimen Inc. (ISPC) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, iSpecimen Inc. reports 115,062 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

iSpecimen Inc.'s basic shares outstanding (115,062) represents currently issued shares. Diluted shares outstanding (115,062) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

iSpecimen Inc.'s float is 137,491 (99.0% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float137,491(99.0%)
Outstanding138,862

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

iSpecimen Inc. (ISPC) shares outstanding history from 2018 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

iSpecimen Inc. shares outstanding for the fiscal year ending December 31, 2025 were 115,062, a 547.47% increase year-over-year. iSpecimen Inc. FY 2025 shares outstanding were 115,062, a +547.47% increase from FY 2024.

iSpecimen Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

ISPC shares outstanding · 4 questions

As of December 31, 2025, iSpecimen Inc. (ISPC) has approximately 115,062 basic shares outstanding and 115,062 diluted shares outstanding. This represents a +547.47% year-over-year increase from FY 2024 (17,771). The increase may reflect equity compensation issuances or secondary offerings.

ISPC shares outstandinghow many shares does ISPC haveISPC basic shares 2025ISPC diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · iSpecimen Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09